| Financial Year |
March 31 2023 |
| Monetary Funds |
211,270,812.05 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
200,328,614.62 |
| Accounts Receivable |
391,036,093.30 |
| Advances to Suppliers |
156,984,146.81 |
| Other Receivables |
49,848,756.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
304,798,333.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
72,654,453.87 |
| Total Current Assets |
1,738,087,133.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
657,865,630.04 |
| Investment Properties |
-- |
| Fixed Assetes |
1,444,327,161.93 |
| Under-construction Projects |
482,582,044.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
278,147,751.15 |
| R&D expenses |
-- |
| Goodwill |
18,021,153.99 |
| Long-Term Deferred and Prepaid Expenses |
17,222,486.67 |
| Deferred Income Tax Assets |
23,400,891.39 |
| Other Non-Current Assets |
205,758,731.08 |
| Sub-Total of Non-Current Assets |
3,583,513,123.88 |
| Total Assets |
5,321,600,257.17 |
| Short-Term Loans |
570,000,000.00 |
| Trading Financial liabilities |
18,209.85 |
| Notes Payable |
212,979,397.58 |
| Accounts Payable |
314,896,203.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
94,699,758.55 |
| Taxes Payable |
27,885,094.39 |
| Interest Payable |
112,361.11 |
| Dividend Payable |
-- |
| Other payables |
118,502,031.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,845,482.11 |
| Other Current Liabilities |
6,575,041.66 |
| Sub-Total of Current Liabilities |
1,459,532,021.19 |
| Long-term Loans |
417,896,390.12 |
| Bonds Payable |
398,472,705.47 |
| Long-Term Accounts Payable |
6,682,057.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,578,420.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
908,914,535.30 |
| Total Liabilities |
2,368,446,556.49 |
| Paid-In Capital(Or Share Stock) |
675,652,277.00 |
| Capital Surplus |
886,102,750.84 |
| Surplus Reserve |
117,041,761.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
991,815,498.76 |
| Minority Stockholder's Interest |
251,928,918.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,701,224,781.86 |
| Owner's Equity（Stockholder's Equity） |
2,953,153,700.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,321,600,257.17 |
